Akbayrak, HakanTekumit, Hayrettin2020-03-262020-03-262019Akbayrak, H., Tekumit, H. (2019). Pulmonary Thromboendarterectomy İn A Combined Thrombophilia Patient. Cardiovasc J Afr, 30,(1), e4-e6.1995-18921680-0745https://dx.doi.org/10.5830/CVJA-2018-052https://hdl.handle.net/20.500.12395/38138Chronic thromboembolic pulmonary hypertension (CTEPH) is a potentially correctable cause of secondary pulmonary hypertension. Surgical treatment remains the primary treatment for patients with CTEPH. Pulmonary thromboendarterectomy (PEA) with deep hypothermic circulatory arrest is the standard and recommended surgical technique for the treatment of these patients. The prevalence of CTEPH after an acute pulmonary thromboembolism (PTE) has been found in various studies to be between 0.6 and 8.8%. Mortality rates in elective PEA cases with CTEPH are reported to be between 1.9 and 4.5%. We report on a 50-year-old female patient with combined inherited thrombophilia, including protein C and protein S deficiencies, who was diagnosed with CTEPH and was successfully treated with pulmonary thromboendarterectomy.en10.5830/CVJA-2018-052info:eu-repo/semantics/openAccessprotein Cprotein Spulmonary embolismthromboendarterectomyArticle301E4E630460973Q3WOS:000459983200002Q4